MedPath

Functional added value of shockwave therapy in persons with a spinal cord injury and spasticity: a multiple single case experimental design study

Conditions
• spinal cord injury (ASIA / AIS score C or D)• Spastic paresis / paralysis in the calf or wrist / hand region
Registration Number
NL-OMON29014
Lead Sponsor
Adelante Zorggroep
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

• Diagnosed with a spinal cord injury (ASIA / AIS score C or D) for more than 6 months.
• Spastic paresis / paralysis in the calf or wrist / hand region (MAS score = 1+).
• Age =18 years.
• No additional orthopedic, rheumatological or neurological co-morbidity that can obscure the answer to the research question.
• No cognitive problems that hinder the participant's understanding of the assignments during the research.
• Adequate knowledge of the Dutch language, i.e. being able to understand the (measurement) assignments.
• Being able to walk 10 meters; regarding ESWT of the calf region.
• Being able to, at least, operate an electric wheelchair with the arm in question; regarding ESWT of the wrist / hand region.

Exclusion Criteria

• Pregnancy.
• Tumor.
• Osteoporosis.
• Thrombosis.
• Polyneuropathy in diabetes.
• Neuromuscular disorders.
• Metal implants in the area to be treated.
• Infection or inflammation of the skin area to be treated.
• Oral anticoagulation medication like coumarine derivatives, DOAC’s or NOAC’s.
• administration of a BoNT injection in the area to be treated within the past 4 months.
• Cortisone therapy up to 6 weeks before the first treatment.
• Pacemaker or electronic implants.
• An intrathecal Baclofen pump.
• Presence of contractures where a reduction in spasticity does not show an improvement in passive range of motion (PROM) in the area to be treated
• No informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
An improvement in the performance of specific ADL tasks for the upper or lower extremities is measured using the Goal Attainment Scaling (GAS).
Secondary Outcome Measures
NameTimeMethod
Secondary outcome measures are: <br>• Active range of motion (AROM)<br>• Passive range of motion (PROM)<br>• 10 meter walk test (10MLT)<br>• Pain perception in the treatment area (VAS)<br>• Short version of the Van Lieshout arm dexterity test for Tetraplegia (VLT-sf) that will be reported descriptively.
© Copyright 2025. All Rights Reserved by MedPath